awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q35501246-76E12CD4-04CB-4DA8-8A5C-A7A223298B0A
Q35501246-76E12CD4-04CB-4DA8-8A5C-A7A223298B0A
BestRank
Statement
http://www.wikidata.org/entity/statement/Q35501246-76E12CD4-04CB-4DA8-8A5C-A7A223298B0A
Chemotherapy and target therapy for hepatocellular carcinoma: New advances and challenges.
P2860
Q35501246-76E12CD4-04CB-4DA8-8A5C-A7A223298B0A
BestRank
Statement
http://www.wikidata.org/entity/statement/Q35501246-76E12CD4-04CB-4DA8-8A5C-A7A223298B0A
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
39b172419c5a31baa294485054ec87ffdb0985b6
P2860
Phase II, open-label study of brivanib as second-line therapy in patients with advanced hepatocellular carcinoma.